中国社区医师
中國社區醫師
중국사구의사
Chinese Community Doctors
2015年
1期
52-52,54
,共2页
恩替卡韦%乙型肝炎%肝衰竭%安全性
恩替卡韋%乙型肝炎%肝衰竭%安全性
은체잡위%을형간염%간쇠갈%안전성
Entecavir%Hepatitis B%Liver failure%Safety
目的：探究恩替卡韦治疗乙型肝炎肝衰竭的临床疗效以及安全性。方法：收治乙型肝炎肝衰竭患者94例，分成观察组和对照组，对照组44例，给予传统综合治疗，观察组50例，在综合治疗基础上加用恩替卡韦进行治疗，观察并记录两组患者的治疗效果以及安全性。结果：观察组治疗总有效率明显高于对照组，且差异均有统计学意义(P＜0.05)。观察组中没有不良反应的发生。结论：应用恩替卡韦治疗乙肝肝衰竭能够收到较好的治疗效果，且安全性较高，值得在临床上推荐应用。
目的：探究恩替卡韋治療乙型肝炎肝衰竭的臨床療效以及安全性。方法：收治乙型肝炎肝衰竭患者94例，分成觀察組和對照組，對照組44例，給予傳統綜閤治療，觀察組50例，在綜閤治療基礎上加用恩替卡韋進行治療，觀察併記錄兩組患者的治療效果以及安全性。結果：觀察組治療總有效率明顯高于對照組，且差異均有統計學意義(P＜0.05)。觀察組中沒有不良反應的髮生。結論：應用恩替卡韋治療乙肝肝衰竭能夠收到較好的治療效果，且安全性較高，值得在臨床上推薦應用。
목적：탐구은체잡위치료을형간염간쇠갈적림상료효이급안전성。방법：수치을형간염간쇠갈환자94례，분성관찰조화대조조，대조조44례，급여전통종합치료，관찰조50례，재종합치료기출상가용은체잡위진행치료，관찰병기록량조환자적치료효과이급안전성。결과：관찰조치료총유효솔명현고우대조조，차차이균유통계학의의(P＜0.05)。관찰조중몰유불량반응적발생。결론：응용은체잡위치료을간간쇠갈능구수도교호적치료효과，차안전성교고，치득재림상상추천응용。
Objective:To explore the clinical efficacy and safety of entecavir in treatment of hepatitis B liver failure.Methods:94 patients with hepatitis B liver failure were selected.They were divided into the observation group and the control group.The control group of 44 cases were given traditional comprehensive treatment,and the observation group of 50 cases were given entecavir therapy on the basis of the comprehensive treatment.We compared the efficacy and safety of the two groups.Results:In the observation group,the total efficiency of treatment was significantly higher than that in the control group,and the difference was statistically significant(P<0.05).There was no adverse reaction in the observation group.Conclusion:The clinical efficacy and safety of entecavir in treatment of hepatitis B liver failure is good,and the security is high.It is worth in the clinical application.
